DataMeds AI, Inc. (MEDS) stock
MEDSNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
$0.74+0.10 (+15.41%)
Close on Nov 18, 2026Market cap $2.26MP/E –Yield –
DataMeds AI operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
DataMeds AI's operating cash flow for the twelve months ending Sep 30, 2026 was -$15.50M. For fiscal 2025 it was -$10.86M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.86M | – |
| FY2024 | Dec 31, 2024 | -$1.22M | – |
| FY2023 | Dec 31, 2023 | -$349.14K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$2.90M | – |
| Q2 FY2026 | Jun 30, 2026 | -$2.89M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.41M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.29M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.14M | -209.4% |
| Q2 FY2025 | Jun 30, 2025 | -$2.08M | -730.1% |
| Q1 FY2025 | Mar 31, 2025 | -$1.35M | -4413.6% |
| Q4 FY2024 | Dec 31, 2024 | -$2.62M | – |
| Q3 FY2024 | Sep 30, 2024 | $1.04M | – |
| Q2 FY2024 | Jun 30, 2024 | $329.96K | – |
| Q1 FY2024 | Mar 31, 2024 | $31.24K | – |
See a number that looks wrong?